BMY Bristol-Myers Squibb Company

BMY (Bristol-Myers Squibb Company) is a US stock trading at $64.15, +0.82% on the day. mdvin's smart-money engine places it in the RUNNING operator phase, with a GRINDER accumulation style. Current conviction is 71/100 and the Buy Score is 88. The active signal is QUIET. It has ignited 1 time(s) in the last 90 sessions, paying off 50% of the time (typical run +2.1%). Reversal/trap risk is graded MEDIUM. On fundamentals it looks fair value (quality grade B, analyst upside +3.20%).